EPO and systemic inflammatory response syndrome: Experimental evidence has identified IL-6 as a key regulator that promotes erythropoietin synthesis during systemic inflammatory response syndrome following septic shock in pediatric populations (Krafte-Jacobs and Bock, 1996).